About this episode
From celery-juice cleanses to infomercial ab-busting gadgets, society has always been on a diet.
It’s a global, multi-billion-dollar powerhouse industry.
The latest trend that you would have heard about are GLP1s, or weight-loss injections.
Pharmac is seeking advice on whether they should be funded for certain people.
Australia’s committed to it for certain patients, taking the cost down to about $29 per script.
A drug like Wegovy for instance, costs about $460 per script in New Zealand.
But, are they really beneficial? Or, is it just the next get skinny quick ploy?
Today on The Front Page, obesity specialist, Dr Gerard McQuinlan is with us to explore whether these drugs should be funded, or is diet and exercise really the only answer?
Follow The Front Page on iHeartRadio, Apple Podcasts, Spotify or wherever you get your podcasts.
You can read more about this and other stories in the New Zealand Herald, online at nzherald.co.nz, or tune in to news bulletins across the NZME network.
Host: Chelsea Daniels
Editor/Producer: Richard Martin
Producer: Jane Yee
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time The Front Page publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Front Page
Are we buying the wrong cars in the fuel crisis EV boom?
The Front Page
How illicit tobacco quietly grew to a quarter of all cigarettes sold here
The Front Page
Why Trump’s Iran blockade could backfire at sea
The Front Page
Inside the push to fix Luxon’s media image
The Front Page